Avalyn Pharma Inc. - common stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 12/08/2026 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 12/08/2026 |
|---|---|---|---|---|
| $2.7 | $1.1 | $1.6 | $1.2 | |
| −$29 | −$27 | −$20 | −$18 | |
| −$0.98 | −$21.83 | −$17.63 | −$63.24 | |
| 30 | — | 1.1 | 0.3 |
Trend